
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT
- About
Global X Aging Population ETF (AGNG)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: AGNG (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type ETF | Historic Profit 6.16% | Avg. Invested days 57 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | ETF Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Volume (30-day avg) 6163 | Beta 0.75 | 52 Weeks Range 27.78 - 33.48 | Updated Date 04/2/2025 |
52 Weeks Range 27.78 - 33.48 | Updated Date 04/2/2025 |
Upturn AI SWOT
Global X Aging Population ETF
ETF Overview
Overview
The Global X Aging Population ETF (GNGE) seeks to invest in companies positioned to benefit from demographic trends associated with global aging. It targets sectors like healthcare, assisted living, pharmaceuticals, and related services. The ETF invests in a basket of global equities.
Reputation and Reliability
Global X is a well-known ETF provider with a solid reputation for thematic and innovative ETFs.
Management Expertise
Global X has a dedicated team of investment professionals with expertise in thematic investing and ETF management.
Investment Objective
Goal
The fund seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index.
Investment Approach and Strategy
Strategy: The ETF tracks the Indxx Global Longevity Thematic Index, a market-capitalization weighted index designed to track the performance of companies that facilitate the aging population.
Composition The ETF primarily holds global equities in sectors that are expected to benefit from an aging population, such as healthcare, pharmaceuticals, and senior living.
Market Position
Market Share: Data not readily available.
Total Net Assets (AUM): 23060000
Competitors
Key Competitors
- IDV (iShares International Select Dividend ETF)
- JHMD (John Hancock Multifactor Developed International ETF)
- EFA (iShares MSCI EAFE ETF)
Competitive Landscape
The competitive landscape includes ETFs focusing on global equity or dividend strategies. GNGE offers a niche focus on the aging population theme. Advantages include its thematic focus, while disadvantages include potentially higher volatility compared to broad market ETFs due to its concentration.
Financial Performance
Historical Performance: Historical performance data requires specific date ranges and is best accessed via financial data providers.
Benchmark Comparison: Benchmark comparison requires access to the Indxx Global Longevity Thematic Index performance data.
Expense Ratio: 0.5
Liquidity
Average Trading Volume
The ETF's average trading volume is moderate, which impacts its liquidity.
Bid-Ask Spread
The bid-ask spread can vary but remains quite tight, indicating reasonable trading costs.
Market Dynamics
Market Environment Factors
Economic indicators, healthcare spending trends, and demographic shifts all influence GNGE. Current market conditions favoring healthcare and defensive sectors may benefit the ETF.
Growth Trajectory
Growth is tied to the increasing global aging population and related healthcare expenditures. No significant changes to strategy or holdings reported.
Moat and Competitive Advantages
Competitive Edge
GNGE's competitive advantage lies in its thematic focus on the aging population, offering investors targeted exposure to this long-term demographic trend. The ETF benefits from Global X's expertise in thematic investing. The fund offers a specialized focus, however, this may come with a higher tracking error than its broader based competitors. This targeted strategy enables investors to capitalize on specific investment strategies.
Risk Analysis
Volatility
GNGE's volatility can be higher compared to broad market ETFs due to its concentrated sector exposure.
Market Risk
Market risk is primarily tied to healthcare sector performance, regulatory changes, and global economic conditions.
Investor Profile
Ideal Investor Profile
The ideal investor is someone seeking long-term growth opportunities linked to demographic shifts. Investors who are focused on the megatrend of aging populations would be interested in this ETF.
Market Risk
GNGE is suitable for long-term investors with a moderate risk tolerance seeking thematic exposure.
Summary
The Global X Aging Population ETF (GNGE) provides targeted exposure to companies poised to benefit from global aging trends. It offers a niche thematic investment strategy, suitable for long-term growth-oriented investors seeking exposure to the healthcare and related sectors. Compared to broad market ETFs, GNGE can exhibit higher volatility due to its focused sector allocation. The ETF's success depends on the continued growth of the aging population and the corresponding demand for healthcare and related services.
Similar Companies
- HEAL
- IHAK
- PJP
- XHE
Sources and Disclaimers
Data Sources:
- Global X ETFs Website
- ETF.com
- Yahoo Finance
- Morningstar
Disclaimers:
Data is based on available information and may be subject to change. Investment decisions should be based on thorough research and consultation with a financial advisor. Market share data is estimated and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Global X Aging Population ETF
Exchange NASDAQ | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.